Kolexia
Fleck Emmanuel
Hématologie
Hopital Saint-louis - La Rochelle
La Rochelle, France
61 Activités
45 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Lymphomes Myélome multiple Lymphome malin non hodgkinien Lymphome B Lymphome T Leucémies Leucémie myéloïde Leucémie myéloïde chronique BCR-ABL positive Lymphome B diffus à grandes cellules

Industries

A+A
18 collaboration(s)
Dernière en 2021
Chugai
4 collaboration(s)
Dernière en 2023
B3TSI
4 collaboration(s)
Dernière en 2021
Janssen
3 collaboration(s)
Dernière en 2021

Dernières activités

Discontinuation of TyrosIne Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) and Impact on the Immune System: Discontinuation of TyrosIne Kinase Inhibitors (ITK) in Chronic Myeloid Leukemia (LMC) and Impact on the Immune System: a Randomized Comparative Study of Two Therapeutic Strategies
Essai Clinique (CHU Poitiers)   19 mars 2024
Combining PET/CT and Ctdna Assessments at 6 Months from Induction Treatment Better Predicts Outcome in Previously Untreated Patients with Follicular Lymphoma: A Relevance Ancillary Lysa Study
65th ASH Annual Meeting Abstracts   02 novembre 2023
MONOMORPHIC EPITHELIOTROPIC INTESTINAL T-CELL LYMPHOMA (MEITL): CLINICO-PATHOLOGICAL ANALYSIS OF A MULTICENTER EUROPEAN COHORT
16th International Conference on Malignant Lymphoma, Virtual Edition, 18–22 June, 2021   17 juin 2021
044 | MONOMORPHIC EPITHELIOTROPIC INTESTINAL T-CELL LYMPHOMA (MEITL): CLINICO-PATHOLOGICAL ANALYSIS OF A MULTICENTER EUROPEAN COHORT
16th International Conference on Malignant Lymphoma, Virtual Edition, 18–22 June, 2021   09 juin 2021
Waldenström macroglobulinemia and relationship to immune deficiency.
Leukemia & lymphoma   04 juin 2021
Low-dose tyrosine kinase inhibitors before treatment discontinuation do not impair treatment-free remission in chronic myeloid leukemia patients: Results of a retrospective study.
Cancer   27 mai 2020
Oral CHOP-like chemotherapy in 60-80 years-old patients with diffuse large B-cell lymphoma.
British journal of haematology   15 juillet 2019
Oral CHOP-like Chemotherapy in Elderly Patients with High-Grade Non Hodgkin B Cell Lymphoma
Blood   29 novembre 2018
Carfilzomib Weekly 20/56mg/m², Lenalidomide and Dexamethasone for Early Relapsed Refractory Multiple Myeloma
Blood   29 novembre 2018
Carfilzomib weekly 20/56 mg/m , lenalidomide and dexamethasone for early relapsed refractory multiple myeloma.
American journal of hematology   25 novembre 2018